Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of olmesartan on blood pressure in patients with hypertension: specification on causality.

× No keyword cloud information.

7 in total

1. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.

Authors: Hisao Ogawa; Shokei Kim-Mitsuyama; Kunihiko Matsui; Tomio Jinnouchi; Hideaki Jinnouchi; Kikuo Arakawa
Journal: Am J Med Date: 2012-04-14 Impact factor: 4.965

2. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.

Authors: Yoshio Matsui; Michael F O'Rourke; Satoshi Hoshide; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal: Hypertension Date: 2012-04-30 Impact factor: 10.190

3. Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies.

Authors: Giuseppe Derosa; Arrigo F G Cicero; Anna Carbone; Fabrizio Querci; Elena Fogari; Angela D'Angelo; Pamela Maffioli
Journal: J Am Soc Hypertens Date: 2013 Jan-Feb

4. The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.

Authors: Mai Yanagi; Kouichi Tamura; Tetsuya Fujikawa; Hiromichi Wakui; Tomohiko Kanaoka; Masato Ohsawa; Kengo Azushima; Akinobu Maeda; Hiroyuki Kobori; Satoshi Umemura
Journal: Hypertens Res Date: 2012-11-15 Impact factor: 3.872

5. Effects of an olmesartan/amlodipine fixed dose on blood pressure control, some adipocytokines and interleukins levels compared with olmesartan or amlodipine monotherapies.

Authors: G Derosa; A F G Cicero; A Carbone; F Querci; E Fogari; A D'Angelo; P Maffioli
Journal: J Clin Pharm Ther Date: 2012-12-05 Impact factor: 2.512

6. Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.

Authors: Ikuo Saito; Kazuomi Kario; Toshio Kushiro; Satoshi Teramukai; Natsuko Zenimura; Katsutoshi Hiramatsu; Fumiaki Kobayashi; Kazuyuki Shimada
Journal: Hypertens Res Date: 2012-10-25 Impact factor: 3.872

7. Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.

Authors: K Kario; I Saito; T Kushiro; S Teramukai; Y Ishikawa; K Hiramatsu; F Kobayashi; K Shimada
Journal: J Hum Hypertens Date: 2013-07-18 Impact factor: 3.012

7 in total

1 in total

1. HONEST to clarify association between home blood pressure and cardiovascular events under antihypertensive medication.

Authors: K Kario
Journal: J Hum Hypertens Date: 2014-01-23 Impact factor: 3.012

1 in total